Mechanism of Action of Racecadotril
Racecadotril works by inhibiting the enzyme neutral endopeptidase (NEP, also called enkephalinase), which normally breaks down endogenous enkephalins in the intestinal wall. By blocking this enzyme, racecadotril allows enkephalins to accumulate and exert their antisecretory effects on the gut, thereby reducing pathologic water and electrolyte hypersecretion into the intestinal lumen without affecting intestinal motility 1, 2.
How It Works at the Molecular Level
The mechanism operates through a specific enzymatic pathway:
- Neutral endopeptidase (NEP) normally degrades enkephalins and other endogenous opioids in the small intestine
- When racecadotril inhibits NEP, enkephalins are protected from degradation and can bind to opioid receptors on intestinal epithelial cells 3, 4
- This enkephalin-mediated effect selectively reduces pathologic secretion of water, sodium, potassium, and chloride into the intestinal lumen during diarrheal states 4
- Importantly, basal intestinal absorption remains unchanged - only the hypersecretion triggered by toxins or pathogens is reduced 4
Key Distinguishing Features
What makes racecadotril unique among antidiarrheal agents:
- No effect on intestinal motility or transit time - unlike loperamide and other opioid-based antidiarrheals, racecadotril does not slow gut movement 1, 2
- Antisecretory without being antimotility - it addresses the secretory component of diarrhea while allowing normal peristalsis to continue 2
- The active metabolite thiorphan does not cross the blood-brain barrier, so there are no central nervous system opioid effects 2
- The antisecretory effect is mediated through peripheral opioid receptors and can be blocked by naloxone 4
Clinical Context
This mechanism explains why racecadotril is recommended as adjunctive therapy to oral rehydration solution in acute diarrhea, particularly in immunotherapy-induced diarrhea 5. It reduces fluid loss without causing the rebound constipation commonly seen with loperamide 3.